Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DM6GKYF)

Drug Name
TTX-080 Drug Info
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Phase 1 [1]
Cross-matching ID
TTD Drug ID
DM6GKYF

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
MHC class I antigen G (HLA-G) TTLKFB3 HLAG_HUMAN Inhibitor [2]

References

1 ClinicalTrials.gov (NCT04485013) TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of Tizona Therapeutics.